These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 134293)

  • 21. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 22. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Sonninen V; Riekkinen P; Rinne UK
    Neurology; 1973 Jul; 23(7):760-3. PubMed ID: 4736494
    [No Abstract]   [Full Text] [Related]  

  • 23. Lumbar cerebrospinal fluid homovanillic acid concentrations are higher in female than male non-human primates.
    Seegal RF
    Brain Res; 1985 May; 334(2):375-9. PubMed ID: 2581673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
    Olsson R; Roos BE
    Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
    [No Abstract]   [Full Text] [Related]  

  • 25. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ; Logue M; Growdon JH
    Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients.
    Jori A; Dolfini E; Casati C; Argenta G
    Psychopharmacologia; 1975 Oct; 44(1):87-90. PubMed ID: 1105628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of a child with familial dysautonomia.
    Andersson H; Hagne I; Roos BE
    Acta Paediatr Scand; 1973 Jan; 62(1):46-8. PubMed ID: 4691255
    [No Abstract]   [Full Text] [Related]  

  • 28. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 29. Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.
    Shaywitz BA; Cohen DJ; Leckman JF; Young JG; Bowers MB
    Dev Med Child Neurol; 1980 Dec; 22(6):748-54. PubMed ID: 6161049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease.
    Gottfries CG; Kjällquist A; Pontén U; Roos BE; Sundbärg G
    Br J Psychiatry; 1974 Mar; 124(0):280-7. PubMed ID: 4836896
    [No Abstract]   [Full Text] [Related]  

  • 32. Probenecid-induced accumulation of cyclic nucleotides, 5-hydroxyindoleacetic acid, and homovanillic acid in cisternal spinal fluid of genetically nervous dogs.
    Angel C; Deluca DC; Murphree OD
    Biol Psychiatry; 1976 Dec; 11(6):743-53. PubMed ID: 187258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebrospinal fluid 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline.
    Bowers MB
    Psychopharmacologia; 1972; 23(1):26-33. PubMed ID: 5018977
    [No Abstract]   [Full Text] [Related]  

  • 35. Steady-state levels of probenecid and their relation to acid monoamine metabolites in human cerebrospinal fluid.
    Sjöström R
    Psychopharmacologia; 1972; 25(1):96-100. PubMed ID: 4261043
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of probenecid and large dose amphetamine administration on cerebrospinal fluid homovanillic acid.
    Angrist BM; Wilk S; Gershon S
    Biol Psychiatry; 1974 Feb; 8(1):113-4. PubMed ID: 4815338
    [No Abstract]   [Full Text] [Related]  

  • 37. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J; Sharpe D; Curzon G
    J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Arch Gen Psychiatry; 1977 May; 34(5):545-50. PubMed ID: 860891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Shaywitz BA; Johnson WT; Bowers M
    Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252
    [No Abstract]   [Full Text] [Related]  

  • 40. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.